Open AccessBrentuximab vedotin in children and adolescents with Hodgkin’s lymphoma and anaplastic large cell lymphoma – literature review and own experience
Author(s) -
Н. В. Мякова,
Д. А. Евстратов,
Д. С. Абрамов,
Д. М. Коновалов,
А. В. Пшонкин,
Dmitry Litvinov
Publication year - 2016
Publication title -
onkogematologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.118
H-Index - 3
eISSN - 2413-4023
pISSN - 1818-8346
DOI - 10.17650/1818-8346-2016-11-1-8-13
Subject(s) - brentuximab vedotin , anaplastic large cell lymphoma , medicine , antibody drug conjugate , oncology , cd30 , lymphoma , refractory (planetary science) , chemotherapy , large cell , hodgkin lymphoma , monoclonal antibody , immunology , antibody , cancer , biology , adenocarcinoma , astrobiology